![Nicholas Jackson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Jackson is currently President-Alliances, Global Research & Development at Clover Biopharmaceuticals Ltd. since 2025.
Dr. Jackson completed undergraduate studies at Oxford Brookes University, graduate studies at the London School of Hygiene & Tropical Medicine, and earned a doctorate from the University of Warwick.
| Unternehmen | Position | Beginn |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Corporate Officer/Principal | 19.10.2025 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Oxford Brookes University
 Oxford Brookes University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Hygiene & Tropical Medicine
 London School of Hygiene & Tropical Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clover Biopharmaceuticals Ltd.
 Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
